{
    "paper_id": "PMC7228302",
    "metadata": {
        "title": "The potential chemical structure of anti\u2010SARS\u2010CoV\u20102 RNA\u2010dependent RNA polymerase",
        "authors": [
            {
                "first": "Jrhau",
                "middle": [],
                "last": "Lung",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Yu\u2010Shih",
                "middle": [],
                "last": "Lin",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Yao\u2010Hsu",
                "middle": [],
                "last": "Yang",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Yu\u2010Lun",
                "middle": [],
                "last": "Chou",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Li\u2010Hsin",
                "middle": [],
                "last": "Shu",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Yu\u2010Ching",
                "middle": [],
                "last": "Cheng",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Hung",
                "middle": [
                    "Te"
                ],
                "last": "Liu",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Ching\u2010Yuan",
                "middle": [],
                "last": "Wu",
                "suffix": "",
                "email": "smbepigwu77@gmail.com",
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "An unprecedented outbreak of coronavirus disease 2019 (COVID\u201019) occurred in Wuhan, Hubei Province, China, in December 2019. It has since spread rapidly to almost all parts of China and many other countries. As at 3 March 2019, the incidence of COVID\u201019 continues to rise.\n1\n\n",
            "cite_spans": [],
            "section": "INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "For coronaviruses, RNA\u2010dependent RNA polymerase (RdRp) is an important enzyme that catalyzes the replication of RNA from RNA templates. Compared the sequence of RdRp in severe acute respiratory syndrome coronavirus (SARS\u2010CoV), SARS\u2010CoV\u20102 and Middle East respiratory syndrome coronavirus (MERS\u2010CoV), SARS\u2010CoV and SARS\u2010CoV\u20102 have remarkably similar sequences, and encode structurally similar structures of RdRp (Figure 1A,B).\n2\n Moreover, RdRp of the three viruses has a huge and deep groove as an active site for the polymerization of RNA and the variations of residues in SARS\u2010CoV\u20102 and SARS\u2010CoV are distal to the active site\n2\n (Figure 1B). Remdesivir (GS\u20105734) is a 1\u2032\u2010cyano\u2010substituted adenosine nucleotide analog inhibitor of RdRp and shows broad\u2010spectrum antiviral activity against several RNA viruses, including Ebola virus, SARS\u2010CoV, and MERS\u2010CoV.\n3\n, \n4\n, \n5\n More importantly, one report indicated that remdesivir improved the critical condition of one COVID\u201019 patient.\n6\n Therefore, RdRp could be an attractive therapeutic target for SARS\u2010CoV\u20102.",
            "cite_spans": [],
            "section": "INTRODUCTION",
            "ref_spans": [
                {
                    "start": 417,
                    "end": 421,
                    "mention": "1A,B",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 637,
                    "end": 639,
                    "mention": "1B",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "In China, many traditional Chinese medicinal compounds have been used to treat SARS\u2010CoV and SARS\u2010CoV\u20102.\n3\n However, the mechanisms of activity and the efficiency of these compounds remain unclear. Therefore, we screened the chemical structures of clinically used traditional Chinese medicinal compounds with proven antiviral activity against SARS\u2010CoV and their similar chemical structures, using a molecular docking method to target RdRp of SARS\u2010CoV\u20102.",
            "cite_spans": [],
            "section": "INTRODUCTION",
            "ref_spans": []
        },
        {
            "text": "The three\u2010dimensional (3D) structure of RdRp of SARS\u2010CoV\u20102 (NCBI Reference Sequence: YP_009725307.1), SARS\u2010CoV (NCBI Reference Sequence: NP_828869.1), and MERS\u2010CoV (NCBI Reference Sequence: YP_009047223.1) were generated based on homologous modeling using Modeller\n7\n incorporated within the UCSF Chimera\n8\n and SWISS\u2010MODEL.\n9\n\n",
            "cite_spans": [],
            "section": "Structure preparation ::: MATERIALS AND METHODS",
            "ref_spans": []
        },
        {
            "text": "Eighty\u2010three chemical structures from traditional Chinese medicinal compounds and their similar structures were retrieved from ZINC15 database.",
            "cite_spans": [],
            "section": "Compound dataset collection ::: MATERIALS AND METHODS",
            "ref_spans": []
        },
        {
            "text": "We used two molecular docking methods for analysis. First, molecular docking and virtual screening was performed using idock download from Github (https://github.com/HongjianLi/idock) in a local Linux machine. Second, the Blind Docking server was used for in silico prediction of the lowest free binding energy. Calculations were carried out with \u201cAchilles\u201d Blind Docking Server, available at: http://bio-hpc.eu/software/blind-docking-server/. The grid box encompassed by the active site (Val557) and surrounding amino acids around the catalytic pocket of SARS\u2010CoV\u20102 RdRp was using for ligand docking and virtual screening (Figure 1B). For each structure, nine docking poses were generated and the scores for the best docking poses of each structure were used for ranking.",
            "cite_spans": [],
            "section": "Molecular docking and virtual screening ::: MATERIALS AND METHODS",
            "ref_spans": [
                {
                    "start": 631,
                    "end": 633,
                    "mention": "1B",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "Screening of these chemical structures revealed that theaflavin (ZINC3978446, Figure 2A) has a lower idock score in the catalytic pocket of RdRp in SARS\u2010CoV\u20102 (\u22129.11 kcal/mol), SARS\u2010CoV (\u22128.03 kcal/mol), and MERS\u2010CoV (\u22128.26 kcal/mol) (Figure 2B). The contact modes between theaflavin and RdRp of these viruses with the lowest idocking scores are illustrated in Figure 2C\u2010E, respectively. Regarding contact modes by idock, hydrophobic interactions contribute significantly in binding and additional hydrogen bonds were found between theaflavin and Asp452, Arg553 and Arg624 of SARS\u2010CoV\u20102 RdRp (Figure 2C), and between theaflavin with Thr440, Ser566, Ala569, and Asp644 of SARS\u2010CoV RdRp (Figure 2D), and between theaflavin with Arg294, Thr292, Gln291, Leu427, Asn 390, Leu427, and Asp728 of MERS\u2010CoV RdRp (Figure 2E).",
            "cite_spans": [],
            "section": "RESULTS",
            "ref_spans": [
                {
                    "start": 85,
                    "end": 87,
                    "mention": "2A",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 242,
                    "end": 244,
                    "mention": "2B",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 368,
                    "end": 372,
                    "mention": "2C\u2010E",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 600,
                    "end": 602,
                    "mention": "2C",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 693,
                    "end": 695,
                    "mention": "2D",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 811,
                    "end": 813,
                    "mention": "2E",
                    "ref_id": "FIGREF1"
                }
            ]
        },
        {
            "text": "Because theaflavin has the lowest idock score in the catalytic pocket of SARS\u2010CoV\u20102 RdRp (\u22129.11 kcal/mol), we used the Blind Docking server to confirm the result. We found that theaflavin has lower binding energy of \u22128.8 kcal/mol when it docks in the catalytic pocket of SARS\u2010CoV\u20102 RdRp. The 2D and 3D contact modes between RdRp and theaflavin with the lowest binding energy are illustrated in Figure 2F,G. Regarding the contact modes by the Blind Docking server, hydrophobic interactions contribute significantly for binding. We observed additional hydrogen bonds and \u03c0\u2010cation interaction between theaflavin and SARS\u2010CoV\u20102 RdRp (Figure 2F,G). The contact mode showed that hydrogen bonds were formed between theaflavin and Asp452, Lys545, Arg555, Thr556, Tyr619, Lys621, Cys622, Asp623, Arg624, and Asp760 of SARS\u2010CoV\u20102 RdRp, near the active site of RdRp. In addition, one \u03c0\u2010cation interaction was formed between theaflavin and Arg553 (Figure 2F,G).",
            "cite_spans": [],
            "section": "RESULTS",
            "ref_spans": [
                {
                    "start": 401,
                    "end": 405,
                    "mention": "2F,G",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 637,
                    "end": 641,
                    "mention": "2F,G",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 943,
                    "end": 947,
                    "mention": "2F,G",
                    "ref_id": "FIGREF1"
                }
            ]
        },
        {
            "text": "Many herbals and compounds used in traditional Chinese medicine have been screened as anti\u2010SARS\u2010CoV therapy.\n10\n, \n11\n, \n12\n, \n13\n, \n14\n Theaflavin, a polyphenolic compound in black tea, is thought to be responsible for the medicinal value of black tea. Theaflavin and theaflavin gallate derivatives have shown broad\u2010spectrum antiviral activity against several viruses, including influenza A and B viruses and hepatitis C virus.\n15\n, \n16\n\n",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "Furthermore, it has been shown that extracts from Pu'er tea and black tea, and theaflavin\u20103,3\u2032\u2010digallate and 3\u2010isotheaflavin\u20103\u2010gallate, in the theaflavins family, have potent inhibitory activity against SARS, by inhibiting SARS\u2010CoV 3CLpro activity.\n17\n In this study, we found that theaflavin was able to dock in the catalytic pocket near the active site of RdRp in SARS\u2010CoV\u20102, SARS\u2010CoV, and MERS\u2010CoV. Furthermore, theaflavin has the lowest idock score and lower binding energy in the catalytic pocket of SARS\u2010CoV\u20102 RdRp in the two different molecular docking methods. We also found that theaflavin formed additional hydrogen bonds and \u03c0\u2010cation interaction with the catalytic pocket of SARS\u2010CoV\u20102 RdRp. This may explain why theaflavin had lower idock score than the other chemical structures that we screened. It is possible that theaflavin could inhibit RdRp activity through blocking the active site in the groove.",
            "cite_spans": [],
            "section": "DISCUSSION",
            "ref_spans": []
        },
        {
            "text": "Our results suggest that theaflavin could be used as a lead compound for developing a SARS\u2010CoV\u20102 inhibitor that targets RdRp. However, the exact in vivo effect is still unclear, and further research is needed to confirm the mechanism whereby theaflavin target SARS\u2010CoV\u20102.",
            "cite_spans": [],
            "section": "CONCLUSION",
            "ref_spans": []
        },
        {
            "text": "The authors declare that there are no conflict of interests.",
            "cite_spans": [],
            "section": "CONFLICT OF INTERESTS",
            "ref_spans": []
        },
        {
            "text": "JL performed the experiments. CYW conceived the idea and designed experiments and wrote the manuscript. YHY, LHS, YCC, HTL, YSL, and JL analyzed the data. YLC revised the English writing of the manuscript. All the authors reviewed and approved the final version.",
            "cite_spans": [],
            "section": "AUTHOR CONTRIBUTIONS",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "FIGREF0": {
            "text": "Figure 1: (A) Sequence alignment for the amino acids of RdRp between SARS\u2010CoV\u20102, SARS\u2010CoV, and MERS\u2010CoV. (B) A modeled structure of SARS\u2010CoV\u20102 RdRp, SARS\u2010CoV RdRp, and MERS\u2010CoV RdRp and Grid box size for binding site using MODELLER. The active site (Val557) and grid box size (light yellow) were showed for binding site. MERS, Middle East respiratory syndrome; RdRp, RNA\u2010dependent RNA polymerase; SARS\u2010CoV, severe acute respiratory syndrome coronavirus",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Figure 2: (A) The structure of theaflavin (ZINC3978446). (B) Red and green molecules, respectively, represent crystallographic and predicted pose for theaflavin. (C\u2010E) The contact model between theaflavin and SARS\u2010CoV\u20102 RdRp (C), SARS\u2010CoV RdRp (D), and MERS\u2010CoV RdRp (E) are shown in two\u2010dimensional (2D) interaction diagram by idock. (F) The contact model between theaflavin and SARS\u2010CoV\u20102 RdRp is shown in the 2D interaction diagram by the Blind Dock server. Their relative distances between amino acid residues and theaflavin are analyzed and illustrated by LigPlot+. Carbon, oxygen, nitrogen, and fluoride molecules are marked as white, red, blue, and green circles, respectively. Covalent bonds in theaflavin and amino acid residues of RdRp are labeled in purple and orange solid lines, respectively. The light blue dot lines label the distance (in \u00c5) of hydrogen bonds formed between the functional moieties of theaflavin and amino acid residues. Hydrophobic interactions between theaflavin and RdRp are depicted by the name of involving amino acid residues, which are labeled with dark green with dark red eyelashes pointing to the involved functional moiety of theaflavin. (G) The hydrogen bonds and \u03c0\u2010cation interaction established by theaflavin with the closest residues are showed through Protein\u2010Ligand Interaction Profiler (PLIP). MERS, Middle East respiratory syndrome; RdRp, RNA\u2010dependent RNA polymerase; SARS\u2010CoV, severe acute respiratory syndrome coronavirus",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Analyzing the epidemiological outbreak of COVID\u201019: a visual exploratory data analysis (EDA) approach",
            "authors": [],
            "year": 2020,
            "venue": "J Med Virol",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1002/jmv.25743"
                ]
            }
        },
        "BIBREF1": {
            "title": "Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019\u2010nCoV",
            "authors": [],
            "year": 2020,
            "venue": "ChemBioChem",
            "volume": "21",
            "issn": "",
            "pages": "730-738",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Potential interventions for novel coronavirus in China: a systematic review",
            "authors": [],
            "year": 2020,
            "venue": "J Med Virol",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1002/jmv.25707"
                ]
            }
        },
        "BIBREF3": {
            "title": "The antiviral compound remdesivir potently inhibits RNA\u2010dependent RNA polymerase from Middle East respiratory syndrome coronavirus",
            "authors": [],
            "year": 2020,
            "venue": "J Biol Chem",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1074/jbc.AC120.013056"
                ]
            }
        },
        "BIBREF4": {
            "title": "Mechanism of inhibition of Ebola virus RNA\u2010dependent RNA polymerase by remdesivir",
            "authors": [],
            "year": 2019,
            "venue": "Viruses",
            "volume": "11",
            "issn": "4",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "First case of 2019 novel coronavirus in the United States",
            "authors": [],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "382",
            "issn": "",
            "pages": "929-936",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "Protein structure modeling with MODELLER",
            "authors": [],
            "year": 2008,
            "venue": "Methods Mol Biol",
            "volume": "426",
            "issn": "",
            "pages": "145-159",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "UCSF Chimera\u2014a visualization system for exploratory research and analysis",
            "authors": [],
            "year": 2004,
            "venue": "J Comput Chem",
            "volume": "25",
            "issn": "13",
            "pages": "1605-1612",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "SWISS\u2010MODEL: homology modelling of protein structures and complexes",
            "authors": [],
            "year": 2018,
            "venue": "Nucleic Acids Res",
            "volume": "46",
            "issn": "W1",
            "pages": "W296-W303",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Effect of integrated traditional Chinese and Western medicine on SARS: a review of clinical evidence",
            "authors": [],
            "year": 2004,
            "venue": "World J Gastroenterol",
            "volume": "10",
            "issn": "23",
            "pages": "3500-3505",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "Glycyrrhizin, an active component of liquorice roots, and replication of SARS\u2010associated coronavirus",
            "authors": [],
            "year": 2003,
            "venue": "Lancet",
            "volume": "361",
            "issn": "9374",
            "pages": "2045-2046",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "Biflavonoids from Torreya nucifera displaying SARS\u2010CoV 3CL(pro) inhibition",
            "authors": [],
            "year": 2010,
            "venue": "Bioorg Med Chem",
            "volume": "18",
            "issn": "22",
            "pages": "7940-7947",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "Tanshinones as selective and slow\u2010binding inhibitors for SARS\u2010CoV cysteine proteases",
            "authors": [],
            "year": 2012,
            "venue": "Bioorg Med Chem",
            "volume": "20",
            "issn": "19",
            "pages": "5928-5935",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells",
            "authors": [],
            "year": 2004,
            "venue": "J Virol",
            "volume": "78",
            "issn": "20",
            "pages": "11334-11339",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "Comparison of in vitro antiviral activity of tea polyphenols against influenza A and B viruses and structure\u2010activity relationship analysis",
            "authors": [],
            "year": 2014,
            "venue": "Fitoterapia",
            "volume": "93",
            "issn": "",
            "pages": "47-53",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culture",
            "authors": [],
            "year": 2018,
            "venue": "PLoS One",
            "volume": "13",
            "issn": "11",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "Inhibition of SARS\u2010CoV 3C\u2010like protease activity by theaflavin\u20103,3\u2032\u2010digallate (TF3)",
            "authors": [],
            "year": 2005,
            "venue": "Evid Based Complement Alternat Med",
            "volume": "2",
            "issn": "2",
            "pages": "209-215",
            "other_ids": {
                "DOI": []
            }
        }
    }
}